MedPath

AERA Pediatrics Registry

Recruiting
Conditions
Dysfunction of Eustachian Tube
Registration Number
NCT07071298
Lead Sponsor
Integra LifeSciences Corporation
Brief Summary

Prospective, multi-center, observational, real-world evidence data collection registry to confirm the continued clinical performance of the AERA® device in pediatric patients

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Age <18
  2. Specific indications for ETBD are documented
  3. ETBD with AERA device attempted-
Exclusion Criteria
  1. ETBD with device other than AERA®
  2. Previous ETBD procedure-

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Failure-free after ETBD with the AERA® device.27 months

Failure is defined as revision ETD surgery (e.g. further ETBD, tympanostomy tube (TT) insertion, or adenoidectomy for ETD).

Secondary Outcome Measures
NameTimeMethod
Tympanogram assessed by ear27 months

Tympanogram

Pure tone audiometry (PTA) assessed by ear27 months

Pure tone audiometry (PTA)

Valsalva maneuver assessed by ear27 months

Valsalva maneuver

Inflammation score assessed by ear27 months

Score 1-4. The higher the score, the worse the outcome.

Eustachian Tube Dysfunction Questionnaire (ETDQ-7) assessed by patient27 months

Total score of 7-49. The higher the score, the worse the outcome.

Otitis Media- 6 Questionnaire (OM-6) assessed by patient27 months

Total score 6-42. The higher the score, the worse the outcome.

Trial Locations

Locations (2)

Michigan Pediatric ENT Associates

🇺🇸

West Bloomfield, Michigan, United States

Ear and Sinus Institute

🇺🇸

Fort Worth, Texas, United States

Michigan Pediatric ENT Associates
🇺🇸West Bloomfield, Michigan, United States
Amanda West
Contact
248-270-6059
amandaw@mpenta.org
Prasad Thottam, DO, FAAP
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.